Free Access
Neuropsychobiology 2011;64:152–162
(DOI:10.1159/000328950)

Bright-Light Therapy in the Treatment of Mood Disorders

Pail G. · Huf W. · Pjrek E. · Winkler D. · Willeit M. · Praschak-Rieder N. · Kasper S.
Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria
email Corresponding Author


 goto top of outline Key Words

  • Depression
  • Seasonal affective disorder
  • Chronobiology
  • Melatonin
  • Serotonin

 goto top of outline Abstract

Bright-light therapy (BLT) is established as the treatment of choice for seasonal affective disorder/winter type (SAD). In the last two decades, the use of BLT has expanded beyond SAD: there is evidence for efficacy in chronic depression, antepartum depression, premenstrual depression, bipolar depression and disturbances of the sleep-wake cycle. Data on the usefulness of BLT in non-seasonal depression are promising; however, further systematic studies are still warranted. In this review, the authors present a comprehensive overview of the literature on BLT in mood disorders. The first part elucidates the neurobiology of circadian and seasonal adaptive mechanisms focusing on the suprachiasmatic nucleus (SCN), the indolamines melatonin and serotonin, and the chronobiology of mood disorders. The SCN is the primary oscillator in humans. Indolamines are known to transduce light signals into cells and organisms since early in evolution, and their role in signalling change of season is still preserved in humans: melatonin is synthesized primarily in the pineal gland and is the central hormone for internal clock circuitries. The melatonin precursor serotonin is known to modulate many behaviours that vary with season. The second part discusses the pathophysiology and clinical specifiers of SAD, which can be seen as a model disorder for chronobiological disturbances and the mechanism of action of BLT. In the third part, the mode of action, application, efficacy, tolerability and safety of BLT in SAD and other mood disorders are explored.

Copyright © 2011 S. Karger AG, Basel


 goto top of outline References
  1. Rosenthal NE, Sack DA, Gillin JC, Lewy AJ, Goodwin FK, Davenport Y, Mueller PS, Newsome DA, Wehr TA: Seasonal affective disorder. A description of the syndrome and preliminary findings with light therapy. Arch Gen Psychiatry 1984;41:72–80.
  2. Horowitz TS, Tanigawa T: Circadian-based new technologies for night workers. Ind Health 2002;40:223–236.
  3. Burgess HJ, Sharkey KM, Eastman CI: Bright light, dark and melatonin can promote circadian adaptation in night shift workers. Sleep Med Rev 2002;6:407–420.

    External Resources

  4. Graf A, Wallner C, Schubert V, Willeit M, Wlk W, Fischer P, Kasper S, Neumeister A: The effects of light therapy on mini-mental state examination scores in demented patients. Biol Psychiatry 2001;50:725–727.
  5. Ancoli-Israel S, Martin JL, Kripke DF, Marler M, Klauber MR: Effect of light treatment on sleep and circadian rhythms in demented nursing home patients. J Am Geriatr Soc 2002;50:282–289.
  6. Terman M, Lewy AJ, Dijk DJ, Boulos Z, Eastman CI, Campbell SS: Light treatment for sleep disorders: consensus report. IV. Sleep phase and duration disturbances. J Biol Rhythms 1995;10:135–147.
  7. Montgomery P, Dennis J: Bright light therapy for sleep problems in adults aged 60+. Cochrane Database Syst Rev 2002:CD003403.
  8. Lam RW, Goldner EM, Solyom L, Remick RA: A controlled study of light therapy for bulimia nervosa. Am J Psychiatry 1994;151:744–750.
  9. Lam RW, Lee SK, Tam EM, Grewal A, Yatham LN: An open trial of light therapy for women with seasonal affective disorder and comorbid bulimia nervosa. J Clin Psychiatry 2001;62:164–168.
  10. Braun DL, Sunday SR, Fornari VM, Halmi KA: Bright light therapy decreases winter binge frequency in women with bulimia nervosa: a double-blind, placebo-controlled study. Compr Psychiatry 1999;40:442–448.
  11. Blouin AG, Blouin JH, Iversen H, Carter J, Goldstein C, Goldfield G, Perez E: Light therapy in bulimia nervosa: a double-blind, placebo-controlled study. Psychiatry Res 1996;60:1–9.
  12. Rybak YE, McNeely HE, Mackenzie BE, Jain UR, Levitan RD: An open trial of light therapy in adult attention-deficit/hyperactivity disorder. J Clin Psychiatry 2006;67:1527–1535.

    External Resources

  13. Monteleone P, Maj M: The circadian basis of mood disorders: recent developments and treatment implications. Eur Neuropsychopharmacol 2008;18:701–711.
  14. Hastings MH: Central clocking. Trends Neurosci 1997;20:459–464.
  15. Klein DC, Moore RY, Reppert SM: Suprachiasmatic Nucleus: the Mind’s Clock. Oxford University Press, 1991.
  16. Hattar S, Lucas RJ, Mrosovsky N, Thompson S, Douglas RH, Hankins MW, Lem J, Biel M, Hofmann F, Foster RG, Yau KW: Melanopsin and rod-cone photoreceptive systems account for all major accessory visual functions in mice. Nature 2003;424:76–81.
  17. Zeitzer JM, Khalsa SB, Boivin DB, Duffy JF, Shanahan TL, Kronauer RE, Czeisler CA: Temporal dynamics of late-night photic stimulation of the human circadian timing system. Am J Physiol Regul Integr Comp Physiol 2005;289:R839–R844.
  18. Moore RY, Speh JC: Serotonin innervation of the primate suprachiasmatic nucleus. Brain Res 2004;1010:169–173.
  19. Stehle JH, von Gall C, Korf HW: Melatonin: a clock-output, a clock-input. J Neuroendocrinol 2003;15:383–389.
  20. Macchi MM, Bruce JN: Human pineal physiology and functional significance of melatonin. Front Neuroendocrinol 2004;25:177–195.
  21. Schibler U, Ripperger J, Brown SA: Peripheral circadian oscillators in mammals: time and food. J Biol Rhythms 2003;18:250–260.
  22. Buijs RM, Kalsbeek A: Hypothalamic integration of central and peripheral clocks. Nat Rev Neurosci 2001;2:521–526.
  23. Wirz-Justice A: Biological rhythm disturbances in mood disorders. Int Clin Psychopharmacol 2006;21(suppl 1):S11–S15.

    External Resources

  24. Lewy AJ, Wehr TA, Goodwin FK, Newsome DA, Markey SP: Light suppresses melatonin secretion in humans. Science 1980;210:1267–1269.
  25. Lerner AB, Case JD, Takahashi Y, Lee TH, Mori N: Isolation of melatonin, a pineal factor that lightens melanocytes. J Am Chem Soc 1958;80:2587.
  26. Pandi-Perumal SR, Trakht I, Srinivasan V, Spence DW, Maestroni GJ, Zisapel N, Cardinali DP: Physiological effects of melatonin: role of melatonin receptors and signal transduction pathways. Prog Neurobiol 2008;85:335–353.
  27. Morgan PJ, Barrett P, Howell HE, Helliwell R: Melatonin receptors: localization, molecular pharmacology and physiological significance. Neurochem Int 1994;24:101–146.
  28. Wehr TA: The durations of human melatonin secretion and sleep respond to changes in daylength (photoperiod). J Clin Endocrinol Metab 1991;73:1276–1280.
  29. Cardinali DP, Pevet P: Basic aspects of melatonin action. Sleep Med Rev 1998;2:175–190.
  30. Liebmann PM, Wolfler A, Felsner P, Hofer D, Schauenstein K: Melatonin and the immune system. Int Arch Allergy Immunol 1997;112:203–211.
  31. Purves D: Neuroscience, ed 4. Chapter Sleep and Wakefulness. Sinauer Associates Inc. Publishers, Massachusetts 2004.
  32. Simonneaux V, Ribelayga C: Generation of the melatonin endocrine message in mammals: a review of the complex regulation of melatonin synthesis by norepinephrine, peptides, and other pineal transmitters. Pharmacol Rev 2003;55:325–395.
  33. Abuja PM, Liebmann P, Hayn M, Schauenstein K, Esterbauer H: Antioxidant role of melatonin in lipid peroxidation of human ldl. FEBS Lett 1997;413:289–293.
  34. Callaway J, Storvik M, Halonen P, Hakko H, Rasanen P, Tiihonen J: Seasonal variations in [3H]citalopram platelet binding between healthy controls and violent offenders in Finland. Hum Psychopharmacol 2005;20:467–472.
  35. Maes M, Scharpe S, Verkerk R, D’Hondt P, Peeters D, Cosyns P, Thompson P, De Meyer F, Wauters A, Neels H: Seasonal variation in plasma l-tryptophan availability in healthy volunteers. Relationships to violent suicide occurrence. Arch Gen Psychiatry 1995;52:937–946.
  36. Sarrias MJ, Artigas F, Martinez E, Gelpi E: Seasonal changes of plasma serotonin and related parameters: correlation with environmental measures. Biol Psychiatry 1989;26:695–706.
  37. Carlsson A, Svennerholm L, Winblad B: Seasonal and circadian monoamine variations in human brains examined post mortem. Acta Psychiatr Scand Suppl 1980;280:75–85.
  38. Lambert GW, Reid C, Kaye DM, Jennings GL, Esler MD: Effect of sunlight and season on serotonin turnover in the brain. Lancet 2002;360:1840–1842.
  39. Kasper S, Wehr TA, Bartko JJ, Gaist PA, Rosenthal NE: Epidemiological findings of seasonal changes in mood and behavior. A telephone survey of montgomery county, maryland. Arch Gen Psychiatry 1989;46:823–833.
  40. Hardin TA, Wehr TA, Brewerton T, Kasper S, Berrettini W, Rabkin J, Rosenthal NE: Evaluation of seasonality in six clinical populations and two normal populations. J Psychiatr Res 1991;25:75–87.
  41. Harris S, Dawson-Hughes B: Seasonal mood changes in 250 normal women. Psychiatry Res 1993;49:77–87.
  42. Okawa M, Shirakawa S, Uchiyama M, Oguri M, Kohsaka M, Mishima K, Sakamoto K, Inoue H, Kamei K, Takahashi K: Seasonal variation of mood and behaviour in a healthy middle-aged population in Japan. Acta Psychiatr Scand 1996;94:211–216.
  43. Hegde AL, Woodson H: Prevalence of seasonal changes in mood and behavior during the winter months in central Texas. Psychiatry Res 1996;62:265–271.
  44. Rohan KJ, Sigmon ST: Seasonal mood patterns in a northeastern college sample. J Affect Disord 2000;59:85–96.
  45. Perry JA, Silvera DH, Rosenvinge JH, Neilands T, Holte A: Seasonal eating patterns in norway: a non-clinical population study. Scand J Psychol 2001;42:307–312.
  46. Chotai J, Smedh K, Johansson C, Nilsson LG, Adolfsson R: An epidemiological study on gender differences in self-reported seasonal changes in mood and behaviour in a general population of northern sweden. Nord J Psychiatry 2004;58:429–437.

    External Resources

  47. Friedman E, Gyulai L, Bhargava M, Landen M, Wisniewski S, Foris J, Ostacher M, Medina R, Thase M: Seasonal changes in clinical status in bipolar disorder: a prospective study in 1000 STEP-BD patients. Acta Psychiatr Scand 2006;113:510–517.
  48. Rudnick G, Clark J: From synapse to vesicle: the reuptake and storage of biogenic amine neurotransmitters. Biochim Biophys Acta 1993;1144:249–263.
  49. Ramamoorthy S, Bauman AL, Moore KR, Han H, Yang-Feng T, Chang AS, Ganapathy V, Blakely RD: Antidepressant- and cocaine-sensitive human serotonin transporter: Molecular cloning, expression, and chromosomal localization. Proc Natl Acad Sci USA 1993;90:2542–2546.
  50. Jennings KA, Loder MK, Sheward WJ, Pei Q, Deacon RM, Benson MA, Olverman HJ, Hastie ND, Harmar AJ, Shen S, Sharp T: Increased expression of the 5-HT transporter confers a low-anxiety phenotype linked to decreased 5-HT transmission. J Neurosci 2006;26:8955–8964.
  51. Praschak-Rieder N, Willeit M, Wilson AA, Houle S, Meyer JH: Seasonal variation in human brain serotonin transporter binding. Arch Gen Psychiatry 2008;65:1072–1078.

    External Resources

  52. Penev PD, Zee PC, Turek FW: Serotonin in the spotlight. Nature 1997;385:123.
  53. Rovescalli AC, Brunello N, Riva M, Galimberti R, Racagni G: Effect of different photoperiod exposure on [3H]imipramine binding and serotonin uptake in the rat brain. J Neurochem 1989;52:507–514.
  54. Kennaway DJ, Moyer RW: Serotonin 5- HT2c agonists mimic the effect of light pulses on circadian rhythms. Brain Res 1998;806:257–270.
  55. Moyer RW, Kennaway DJ, Ferguson SA, Dijstelbloem YP: Quipazine and light have similar effects on c-fos induction in the rat suprachiasmatic nucleus. Brain Res 1997;765:337–342.
  56. Moyer RW, Kennaway DJ: Serotonin depletion decreases light induced c-fos in the rat suprachiasmatic nucleus. Neuroreport 2000;11:1021–1024.
  57. Chew KS, McCleary R: The spring peak in suicides: a cross-national analysis. Soc Sci Med 1995;40:223–230.
  58. Rocchi MB, Perlini C: Is the time of suicide a random choice? A new statistical perspective. Crisis 2002;23:161–166.
  59. Partonen T, Haukka J, Viilo K, Hakko H, Pirkola S, Isometsa E, Lonnqvist J, Sarkioja T, Vaisanen E, Rasanen P: Cyclic time patterns of death from suicide in northern Finland. J Affect Disord 2004;78:11–19.

    External Resources

  60. Bjorksten KS, Bjerregaard P, Kripke DF: Suicides in the midnight sun – a study of seasonality in suicides in west Greenland. Psychiatry Res 2005;133:205–213.
  61. Parker G, Gao F, Machin D: Seasonality of suicide in singapore: data from the equator. Psychol Med 2001;31:549–553.
  62. Van Cauter E, Turek FW: Depression: a disorder of timekeeping? Perspect Biol Med 1986;29:510–519.
  63. Gorwood P: Depression and circadian rhythm disturbances. Medicographia 2007;29:22–27.
  64. Kupfer DJ: REM latency: a psychobiologic marker for primary depressive disease. Biol Psychiatry 1976;11:159–174.
  65. Ansseau M, Kupfer DJ, Reynolds CF 3rd, McEachran AB: REM latency distribution in major depression: clinical characteristics associated with sleep onset rem periods. Biol Psychiatry 1984;19:1651–1666.
  66. Brunello N, Armitage R, Feinberg I, Holsboer-Trachsler E, Leger D, Linkowski P, Mendelson WB, Racagni G, Saletu B, Sharpley AL, Turek F, Van Cauter E, Mendlewicz J: Depression and sleep disorders: clinical relevance, economic burden and pharmacological treatment. Neuropsychobiology 2000;42:107–119.
  67. Ford DE, Kamerow DB: Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention? JAMA 1989;262:1479–1484.
  68. Eaton WW, Badawi M, Melton B: Prodromes and precursors: epidemiologic data for primary prevention of disorders with slow onset. Am J Psychiatry 1995;152:967–972.
  69. Claustrat B, Brun J, Chazot G: The basic physiology and pathophysiology of melatonin. Sleep Med Rev 2005;9:11–24.
  70. Van Cauter E, Leproult R, Kupfer DJ: Effects of gender and age on the levels and circadian rhythmicity of plasma cortisol. J Clin Endocrinol Metab 1996;81:2468–2473.
  71. Linkowski P, Mendlewicz J, Leclercq R, Brasseur M, Hubain P, Golstein J, Copinschi G, Van Cauter E: The 24-hour profile of adrenocorticotropin and cortisol in major depressive illness. J Clin Endocrinol Metab 1985;61:429–438.
  72. Linkowski P, Van Cauter E, Leclercq R, Desmedt D, Brasseur M, Golstein J, Copinschi G, Mendlewicz J: ACTH, cortisol and growth hormone 24-hour profiles in major depressive illness. Acta Psychiatr Belg 1985;85:615–623.
  73. Mendlewicz J, Linkowski P, Kerkhofs M, Desmedt D, Golstein J, Copinschi G, Van Cauter E: Diurnal hypersecretion of growth hormone in depression. J Clin Endocrinol Metab 1985;60:505–512.
  74. Kijne B, Aggernaes H, Fog-Moller F, Andersen HH, Nissen J, Kirkegaard C, Bjorum N: Circadian variation of serum thyrotropin in endogenous depression. Psychiatry Res 1982;6:277–282.
  75. Scheer FA, Czeisler CA: Melatonin, sleep, and circadian rhythms. Sleep Med Rev 2005;9:5–9.

    External Resources

  76. Beck-Friis J, Ljunggren JG, Thoren M, von Rosen D, Kjellman BF, Wetterberg L: Melatonin, cortisol and ACTH in patients with major depressive disorder and healthy humans with special reference to the outcome of the dexamethasone suppression test. Psychoneuroendocrinology 1985;10:173–186.
  77. Brown RP, Caroff S, Kocsis JH, Amsterdam J, Winokur A, Stokes P, Frazer A: Nocturnal serum melatonin in major depressive disorder before and after desmethylimipramine treatment. Psychopharmacol Bull 1985;21:579–581.
  78. Souetre E, Salvati E, Belugou JL, Pringuey D, Candito M, Krebs B, Ardisson JL, Darcourt G: Circadian rhythms in depression and recovery: evidence for blunted amplitude as the main chronobiological abnormality. Psychiatry Res 1989;28:263–278.
  79. Avery DH, Wildschiodtz G, Rafaelsen OJ: Nocturnal temperature in affective disorder. J Affect Disord 1982;4:61–71.
  80. Tsujimoto T, Yamada N, Shimoda K, Hanada K, Takahashi S: Circadian rhythms in depression. Part II. Circadian rhythms in inpatients with various mental disorders. J Affect Disord 1990;18:199–210.
  81. Dietzel M, Saletu B, Lesch OM, Sieghart W, Schjerve M: Light treatment in depressive illness. Polysomnographic, psychometric and neuroendocrinological findings. Eur Neurol 1986;25(suppl 2):93–103.

    External Resources

  82. Goetze U, Tolle R: Circadian rhythm of free urinary cortisol, temperature and heart rate in endogenous depressives and under antidepressant therapy. Neuropsychobiology 1987;18:175–184.
  83. Parry BL, Mendelson WB, Duncan WC, Sack DA, Wehr TA: Longitudinal sleep EEG, temperature, and activity measurements across the menstrual cycle in patients with premenstrual depression and in age-matched controls. Psychiatry Res 1989;30:285–303.
  84. Benca RM, Obermeyer WH, Thisted RA, Gillin JC: Sleep and psychiatric disorders. A meta-analysis. Arch Gen Psychiatry 1992;49:651–668; discussion 669–670.
  85. Wirz-Justice A: Diurnal variation of depressive symptoms. Dialogues Clin Neurosci 2008;10:337–343.
  86. Lewy AJ, Kern HA, Rosenthal NE, Wehr TA: Bright artificial light treatment of a manic-depressive patient with a seasonal mood cycle. Am J Psychiatry 1982;139:1496–1498.
  87. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4, text revision (DSM-IV-TR). Washington, American Psychiatric Press, 2000.
  88. Winkler D, Pjrek E, Iwaki R, Kasper S: Treatment of seasonal affective disorder. Expert Rev Neurother 2006;6:1039–1048.
  89. Kasper S, Rogers SL, Yancey A, Schulz PM, Skwerer RG, Rosenthal NE: Phototherapy in individuals with and without subsyndromal seasonal affective disorder. Arch Gen Psychiatry 1989;46:837–844.
  90. Praschak-Rieder N, Willeit M: Treatment of seasonal affective disorder. Dialogues Clin Neurosci 2003;5:389–398.
  91. Winkler D, Willeit M, Praschak-Rieder N, Lucht MJ, Hilger E, Konstantinidis A, Stastny J, Thierry N, Pjrek E, Neumeister A, Moller HJ, Kasper S: Changes of clinical pattern in seasonal affective disorder (SAD) over time in a German-speaking sample. Eur Arch Psychiatry Clin Neurosci 2002;252:54–62.
  92. Winkler D, Pjrek E, Konstantinidis A, Praschak-Rieder N, Willeit M, Stastny J, Kasper S: Anger attacks in seasonal affective disorder. Int J Neuropsychopharmacol 2006;9:215–219.

    External Resources

  93. Praschak-Rieder N, Willeit M, Neumeister A, Hilger E, Stastny J, Thierry N, Lenzinger E, Kasper S: Prevalence of premenstrual dysphoric disorder in female patients with seasonal affective disorder. J Affect Disord 2001;63:239–242.
  94. Lam RW, Carter D, Misri S, Kuan AJ, Yatham LN, Zis AP: A controlled study of light therapy in women with late luteal phase dysphoric disorder. Psychiatry Res 1999;86:185–192.
  95. Levitt AJ, Boyle MH, Joffe RT, Baumal Z: Estimated prevalence of the seasonal subtype of major depression in a Canadian community sample. Can J Psychiatry 2000;45:650–654.
  96. Winkler D, Praschak-Rieder N, Willeit M, Lucht MJ, Hilger E, Konstantinidis A, Stastny J, Thierry N, Pjrek E, Neumeister A, Moller HJ, Kasper S: Seasonal affective depression in 2 German-speaking university centers: Bonn, Vienna. Clinical and demographic characteristics (in German). Nervenarzt 2002;73:637–643.
  97. Levitan RD: The chronobiology and neurobiology of winter seasonal affective disorder. Dialogues Clin Neurosci 2007;9:315–324.
  98. Rosen LN, Targum SD, Terman M, Bryant MJ, Hoffman H, Kasper SF, Hamovit JR, Docherty JP, Welch B, Rosenthal NE: Prevalence of seasonal affective disorder at four latitudes. Psychiatry Res 1990;31:131–144.
  99. Michalak EE, Lam RW: Seasonal affective disorder: the latitude hypothesis revisited. Can J Psychiatry 2002;47:787–788.

    External Resources

  100. Levitt AJ, Boyle MH: The impact of latitude on the prevalence of seasonal depression. Can J Psychiatry 2002;47:361–367.

    External Resources

  101. Danilenko KV, Putilov AA, Russkikh GS, Duffy LK, Ebbesson SO: Diurnal and seasonal variations of melatonin and serotonin in women with seasonal affective disorder. Arctic Med Res 1994;53:137–145.
  102. Wehr TA, Duncan WC Jr, Sher L, Aeschbach D, Schwartz PJ, Turner EH, Postolache TT, Rosenthal NE: A circadian signal of change of season in patients with seasonal affective disorder. Arch Gen Psychiatry 2001;58:1108–1114.
  103. Dahl K, Avery DH, Lewy AJ, Savage MV, Brengelmann GL, Larsen LH, Vitiello MV, Prinz PN: Dim light melatonin onset and circadian temperature during a constant routine in hypersomnic winter depression. Acta Psychiatr Scand 1993;88:60–66.
  104. Checkley SA, Murphy DG, Abbas M, Marks M, Winton F, Palazidou E, Murphy DM, Franey C, Arendt J: Melatonin rhythms in seasonal affective disorder. Br J Psychiatry 1993;163:332–337.
  105. Partonen T, Vakkuri O, Lamberg-Allardt C, Lonnqvist J: Effects of bright light on sleepiness, melatonin, and 25-hydroxyvitamin D3 in winter seasonal affective disorder. Biol Psychiatry 1996;39:865–872.
  106. Murray G, Michalak EE, Levitt AJ, Levitan RD, Enns MW, Morehouse R, Lam RW: Therapeutic mechanism in seasonal affective disorder: do fluoxetine and light operate through advancing circadian phase? Chronobiol Int 2005;22:937–943.
  107. Murray G, Michalak EE, Levitt AJ, Levitan RD, Enns MW, Morehouse R, Lam RW: O sweet spot where art thou? Light treatment of seasonal affective disorder and the circadian time of sleep. J Affect Disord 2006;90:227–231.

    External Resources

  108. Winkler D, Pjrek E, Praschak-Rieder N, Willeit M, Pezawas L, Konstantinidis A, Stastny J, Kasper S: Actigraphy in patients with seasonal affective disorder and healthy control subjects treated with light therapy. Biol Psychiatry 2005;58:331–336.

    External Resources

  109. Willeit M, Sitte HH, Thierry N, Michalek K, Praschak-Rieder N, Zill P, Winkler D, Brannath W, Fischer MB, Bondy B, Kasper S, Singer EA: Enhanced serotonin transporter function during depression in seasonal affective disorder. Neuropsychopharmacology 2008;33:1503–1513.
  110. Willeit M, Praschak-Rieder N, Neumeister A, Pirker W, Asenbaum S, Vitouch O, Tauscher J, Hilger E, Stastny J, Brucke T, Kasper S: [123I]-β-CIT SPECT imaging shows reduced brain serotonin transporter availability in drug-free depressed patients with seasonal affective disorder. Biol Psychiatry 2000;47:482–489.
  111. Lehto S, Tolmunen T, Joensuu M, Saarinen PI, Vanninen R, Ahola P, Tiihonen J, Kuikka J, Lehtonen J: Midbrain binding of [123I]nor-β-CIT in atypical depression. Prog Neuropsychopharmacol Biol Psychiatry 2006;30:1251–1255.
  112. Neumeister A, Praschak-Rieder N, Besselmann B, Rao ML, Gluck J, Kasper S: Effects of tryptophan depletion on drug-free patients with seasonal affective disorder during a stable response to bright light therapy. Arch Gen Psychiatry 1997;54:133–138.
  113. Neumeister A, Praschak-Rieder N, Hesselmann B, Vitouch O, Rauh M, Barocka A, Kasper S: Effects of tryptophan depletion in fully remitted patients with seasonal affective disorder during summer. Psychol Med 1998;28:257–264.
  114. Lam RW, Bowering TA, Tam EM, Grewal A, Yatham LN, Shiah IS, Zis AP: Effects of rapid tryptophan depletion in patients with seasonal affective disorder in natural summer remission. Psychol Med 2000;30:79–87.
  115. Neumeister A, Turner EH, Matthews JR, Postolache TT, Barnett RL, Rauh M, Vetticad RG, Kasper S, Rosenthal NE: Effects of tryptophan depletion vs catecholamine depletion in patients with seasonal affective disorder in remission with light therapy. Arch Gen Psychiatry 1998;55:524–530.
  116. Lam RW, Tam EM, Grewal A, Yatham LN: Effects of α-methyl-para-tyrosine-induced catecholamine depletion in patients with seasonal affective disorder in summer remission. Neuropsychopharmacology 2001;25:S97–S101.
  117. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, Benjamin J, Muller CR, Hamer DH, Murphy DL: Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996;274:1527–1531.
  118. Hu XZ, Lipsky RH, Zhu G, Akhtar LA, Taubman J, Greenberg BD, Xu K, Arnold PD, Richter MA, Kennedy JL, Murphy DL, Goldman D: Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. Am J Hum Genet 2006;78:815–826.
  119. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, McClay J, Mill J, Martin J, Braithwaite A, Poulton R: Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 2003;301:386–389.
  120. Risch N, Herrell R, Lehner T, Liang KY, Eaves L, Hoh J, Griem A, Kovacs M, Ott J, Merikangas KR: Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression: a meta-analysis. JAMA 2009;301:2462–2471.
  121. Rosenthal NE, Mazzanti CM, Barnett RL, Hardin TA, Turner EH, Lam GK, Ozaki N, Goldman D: Role of serotonin transporter promoter repeat length polymorphism (5-HTTLPR) in seasonality and seasonal affective disorder. Mol Psychiatry 1998;3:175–177.
  122. Sher L, Hardin TA, Greenberg BD, Murphy DL, Li Q, Rosenthal NE: Seasonality associated with the serotonin transporter promoter repeat length polymorphism. Am J Psychiatry 1999;156:1837.
  123. Johansson C, Willeit M, Levitan R, Partonen T, Smedh C, Del Favero J, Bel Kacem S, Praschak-Rieder N, Neumeister A, Masellis M, Basile V, Zill P, Bondy B, Paunio T, Kasper S, Van Broeckhoven C, Nilsson LG, Lam R, Schalling M, Adolfsson R: The serotonin transporter promoter repeat length polymorphism, seasonal affective disorder and seasonality. Psychol Med 2003;33:785–792.
  124. Willeit M, Praschak-Rieder N, Neumeister A, Zill P, Leisch F, Stastny J, Hilger E, Thierry N, Konstantinidis A, Winkler D, Fuchs K, Sieghart W, Aschauer H, Ackenheil M, Bondy B, Kasper S: A polymorphism (5-HTTLPR) in the serotonin transporter promoter gene is associated with DSM-IV depression subtypes in seasonal affective disorder. Mol Psychiatry 2003;8:942–946.
  125. Baune BT, Hohoff C, Mortensen LS, Deckert J, Arolt V, Domschke K: Serotonin transporter polymorphism (5-HTTLPR) association with melancholic depression: a female specific effect? Depress Anxiety 2008;25:920–925.
  126. Terman M, Terman JS: Light therapy for seasonal and nonseasonal depression: efficacy, protocol, safety, and side effects. CNS Spectr 2005;10:647–663; quiz 672.
  127. Koorengevel KM, Gordijn MC, Beersma DG, Meesters Y, den Boer JA, van den Hoofdakker RH, Daan S: Extraocular light therapy in winter depression: a double-blind placebo-controlled study. Biol Psychiatry 2001;50:691–698.
  128. Terman JS, Terman M, Schlager D, Rafferty B, Rosofsky M, Link MJ, Gallin PF, Quitkin FM: Efficacy of brief, intense light exposure for treatment of winter depression. Psychopharmacol Bull 1990;26:3–11.
  129. Terman M, Amira L, Terman JS, Ross DC: Predictors of response and nonresponse to light treatment for winter depression. Am J Psychiatry 1996;153:1423–1429.
  130. Partonen T: Effects of morning light treatment on subjective sleepiness and mood in winter depression. J Affect Disord 1994;30:47–56.
  131. Berson DM, Dunn FA, Takao M: Phototransduction by retinal ganglion cells that set the circadian clock. Science 2002;295:1070–1073.
  132. Peirson S, Foster RG: Melanopsin: another way of signaling light. Neuron 2006;49:331–339.
  133. Cajochen C: Alerting effects of light. Sleep Med Rev 2007;11:453–464.

    External Resources

  134. Anderson JL, Glod CA, Dai J, Cao Y, Lockley SW: Lux vs. wavelength in light treatment of seasonal affective disorder. Acta Psychiatr Scand 2009;120:203–212.
  135. Glickman G, Byrne B, Pineda C, Hauck WW, Brainard GC: Light therapy for seasonal affective disorder with blue narrow-band light-emitting diodes (leds). Biol Psychiatry 2006;59:502–507.
  136. Wirz-Justice A, Graw P, Kräuchi K, Haug H, Leonhardt G, Brunner D: Effect of light on unmasked circadian rhythms in winter depression. Oxford, Pergamon Press, 1993.
  137. Aries MBC: Human lighting demands: healthy lighting in an office environment. Eindhoven, Eindhoven University Press, 2005, p 158.
  138. Teicher MH, Glod CA, Oren DA, Schwartz PJ, Luetke C, Brown C, Rosenthal NE: The phototherapy light visor: more to it than meets the eye. Am J Psychiatry 1995;152:1197–1202.
  139. Joffe RT, Moul DE, Lam RW, Levitt AJ, Teicher MH, Lebegue B, Oren DA, Buchanan A, Glod CA, Murray MG, et al: Light visor treatment for seasonal affective disorder: a multicenter study. Psychiatry Res 1993;46:29–39.
  140. Leppamaki S, Meesters Y, Haukka J, Lonnqvist J, Partonen T: Effect of simulated dawn on quality of sleep – a community-based trial. BMC Psychiatry 2003;3:14.

    External Resources

  141. Konstantinidis A, Winkler D: Lichttherapie: Parameter und praktische Hinweise zur Anwendung. Herbst-/Winterdepression und Lichttherapie. Berlin, Springer, 2004, pp 133–144.
  142. Lam RW, Levitt AJ: Canadian consensus-guidelines for the treatment of SAD. A summary of the report of the Canadian consensus group on SAD. Vancouver, Clinical and Academic Publishing, 1999.
  143. Michalak EE, Murray G, Wilkinson C, Dowrick C, Lam RW: A pilot study of adherence with light treatment for seasonal affective disorder. Psychiatry Res 2007;149:315–320.

    External Resources

  144. Partonen T, Lonnqvist J: Prevention of winter seasonal affective disorder by bright-light treatment. Psychol Med 1996;26:1075–1080.
  145. Meesters Y, Beersma DG, Bouhuys AL, van den Hoofdakker RH: Prophylactic treatment of seasonal affective disorder (SAD) by using light visors: bright white or infrared light? Biol Psychiatry 1999;46:239–246.
  146. Williams JBW, Link MJ, Rosenthal NE: Structured interview guide for the Hamilton Depression Rating Scale – seasonal affective disorder version (SIGH-SAD). New York, New York State Psychiatric Institute, 2002.
  147. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56–62.
  148. Eastman CI, Lahmeyer HW, Watell LG, Good GD, Young MA: A placebo-controlled trial of light treatment for winter depression. J Affect Disord 1992;26:211–221.
  149. Eastman CI, Young MA, Fogg LF, Liu L, Meaden PM: Bright light treatment of winter depression: a placebo-controlled trial. Arch Gen Psychiatry 1998;55:883–889.
  150. Wirz-Justice A: Beginning to see the light. Arch Gen Psychiatry 1998;55:861–862.
  151. Terman M, Terman JS, Ross DC: A controlled trial of timed bright light and negative air ionization for treatment of winter depression. Arch Gen Psychiatry 1998;55:875–882.
  152. Golden RN, Gaynes BN, Ekstrom RD, Hamer RM, Jacobsen FM, Suppes T, Wisner KL, Nemeroff CB: The efficacy of light therapy in the treatment of mood disorders: a review and meta-analysis of the evidence. Am J Psychiatry 2005;162:656–662.
  153. Martiny K, Lunde M, Unden M, Dam H, Bech P: Adjunctive bright light in non-seasonal major depression: results from clinician-rated depression scales. Acta Psychiatr Scand 2005;112:117–125.
  154. Terman M, Terman JS, Quitkin FM, McGrath PJ, Stewart JW, Rafferty B: Light therapy for seasonal affective disorder. A review of efficacy. Neuropsychopharmacology 1989;2:1–22.
  155. Lewy AJ, Bauer VK, Cutler NL, Sack RL, Ahmed S, Thomas KH, Blood ML, Jackson JM: Morning vs evening light treatment of patients with winter depression. Arch Gen Psychiatry 1998;55:890–896.
  156. Lewy AJ, Sack RL, Miller LS, Hoban TM: Antidepressant and circadian phase-shifting effects of light. Science 1987;235:352–354.
  157. Lewy AJ, Lefler BJ, Emens JS, Bauer VK: The circadian basis of winter depression. Proc Natl Acad Sci USA 2006;103:7414–7419.
  158. Benedetti F, Barbini B, Fulgosi MC, Colombo C, Dallaspezia S, Pontiggia A, Smeraldi E: Combined total sleep deprivation and light therapy in the treatment of drug-resistant bipolar depression: acute response and long-term remission rates. J Clin Psychiatry 2005;66:1535–1540.
  159. Lam RW, Zis AP, Goumeniouk AD: Somatic treatments for bipolar disorder; in Yatham LN, Kusumakar V, Kutcher SP (eds): Bipolar Disorder: A Clinician’s Guide to Biological Treatments. Amsterdam, Harwood Academic Publishers, 2002, pp 246–263.
  160. Deltito JA, Moline M, Pollak C, Martin LY, Maremmani I: Effects of phototherapy on non-seasonal unipolar and bipolar depressive spectrum disorders. J Affect Disord 1991;23:231–237.
  161. Chan PK, Lam RW, Perry KF: Mania precipitated by light therapy for patients with SAD. J Clin Psychiatry 1994;55:454.
  162. Schwitzer J, Neudorfer C, Blecha HG, Fleischhacker WW: Mania as a side effect of phototherapy. Biol Psychiatry 1990;28:532–534.
  163. Kripke DF: Timing of phototherapy and occurrence of mania. Biol Psychiatry 1991;29:1156–1157.
  164. Sit D, Wisner KL, Hanusa BH, Stull S, Terman M: Light therapy for bipolar disorder: a case series in women. Bipolar Disord 2007;9:918–927.
  165. Wu JC, Kelsoe JR, Schachat C, Bunney BG, Demodena A, Golshan S, Gillin JC, Potkin SG, Bunney WE: Rapid and sustained antidepressant response with sleep deprivation and chronotherapy in bipolar disorder. Biol Psychiatry 2009;66:298–301.
  166. Goel N, Terman M, Terman JS, Macchi MM, Stewart JW: Controlled trial of bright light and negative air ions for chronic depression. Psychol Med 2005;35:945–955.
  167. Oren DA, Wisner KL, Spinelli M, Epperson CN, Peindl KS, Terman JS, Terman M: An open trial of morning light therapy for treatment of antepartum depression. Am J Psychiatry 2002;159:666–669.
  168. Epperson CN, Terman M, Terman JS, Hanusa BH, Oren DA, Peindl KS, Wisner KL: Randomized clinical trial of bright light therapy for antepartum depression: preliminary findings. J Clin Psychiatry 2004;65:421–425.
  169. Wirz-Justice A, Benedetti F, Berger M, Lam RW, Martiny K, Terman M, Wu JC: Chronotherapeutics (light and wake therapy) in affective disorders. Psychol Med 2005;35:939–944.
  170. Neumeister A, Praschak-Rieder N, Hesselmann B, Vitouch O, Rauh M, Barocka A, Tauscher J, Kasper S: Effects of tryptophan depletion in drug-free depressed patients who responded to total sleep deprivation. Arch Gen Psychiatry 1998;55:167–172.
  171. Praschak-Rieder N, Willeit M, Neumeister A, Hilger E, Kasper S: Therapeutic sleep deprivation and phototherapy (in German). Wien Med Wochenschr 1999;149:520–524.
  172. Neumeister A, Goessler R, Lucht M, Kapitany T, Bamas C, Kasper S: Bright light therapy stabilizes the antidepressant effect of partial sleep deprivation. Biol Psychiatry 1996;39:16–21.
  173. Colombo C, Lucca A, Benedetti F, Barbini B, Campori E, Smeraldi E: Total sleep deprivation combined with lithium and light therapy in the treatment of bipolar depression: replication of main effects and interaction. Psychiatry Res 2000;95:43–53.
  174. Parry BL, Berga SL, Mostofi N, Sependa PA, Kripke DF, Gillin JC: Morning versus evening bright light treatment of late luteal phase dysphoric disorder. Am J Psychiatry 1989;146:1215–1217.
  175. Parry BL, Mahan AM, Mostofi N, Klauber MR, Lew GS, Gillin JC: Light therapy of late luteal phase dysphoric disorder: an extended study. Am J Psychiatry 1993;150:1417–1419.
  176. Pjrek E, Konstantinidis A, Assem-Hilger E, Praschak-Rieder N, Willeit M, Kasper S, Winkler D: Therapeutic effects of escitalopram and reboxetine in seasonal affective disorder: a pooled analysis. J Psychiatr Res 2009;43:792–797.

    External Resources

  177. Pjrek E, Winkler D, Stastny J, Konstantinidis A, Heiden A, Kasper S: Bright light therapy in seasonal affective disorder – does it suffice? Eur Neuropsychopharmacol 2004;14:347–351.
  178. Terman M, Terman JS: Bright light therapy: side effects and benefits across the symptom spectrum. J Clin Psychiatry 1999;60:799–808; quiz 809.
  179. Labbate LA, Lafer B, Thibault A, Sachs GS: Side effects induced by bright light treatment for seasonal affective disorder. J Clin Psychiatry 1994;55:189–191.
  180. Swiecicki L: Phototherapy for winter depression: report of three cases (in Polish). Psychiatr Pol 1993;27:667–672.
  181. Praschak-Rieder N, Neumeister A, Hesselmann B, Willeit M, Barnas C, Kasper S: Suicidal tendencies as a complication of light therapy for seasonal affective disorder: a report of three cases. J Clin Psychiatry 1997;58:389–392.
  182. Haffmans J, Lucius S, Ham N: Suicide after bright light treatment in seasonal affective disorder: a case report. J Clin Psychiatry 1998;59:478.
  183. Pjrek E, Winkler D, Willeit M, Konstantinidis A, Thierry N, Kasper S: Menstrual disturbances a rare side-effect of bright-light therapy. Int J Neuropsychopharmacol 2004;7:239–240.

    External Resources

  184. Dureau P, Jeanny JC, Clerc B, Dufier JL, Courtois Y: Long term light-induced retinal degeneration in the miniature pig. Mol Vis 1996;2:7.
  185. Gallin PF, Terman M, Reme CE, Rafferty B, Terman JS, Burde RM: Ophthalmologic examination of patients with seasonal affective disorder, before and after bright light therapy. Am J Ophthalmol 1995;119:202–210.

 goto top of outline Author Contacts

Siegfried Kasper, MD
Department of Psychiatry and Psychotherapy
Medical University of Vienna, Währinger Gürtel 18–20
AT–1090 Vienna (Austria)
Tel. +43 1 40400 3568, E-Mail sci-biolpsy@meduniwien.ac.at


 goto top of outline Article Information

Received: March 27, 2009
Accepted after revision: August 11, 2009
Published online: July 29, 2011
Number of Print Pages : 11
Number of Figures : 0, Number of Tables : 3, Number of References : 185


 goto top of outline Publication Details

Neuropsychobiology (International Journal of Experimental and Clinical Research in Biological Psychiatry, Pharmacopsychiatry, Biological Psychology/Pharmacopsychology and Pharmacoelectroencephalography)

Vol. 64, No. 3, Year 2011 (Cover Date: July 2011)

Journal Editor: Strik W. (Bern)
ISSN: 0302-282X (Print), eISSN: 1423-0224 (Online)

For additional information: http://www.karger.com/NPS


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.